Journal of Dental Anesthesia and Pain Medicine

The Korean Dental Society of Anesthsiology (대한치과마취과학회)
권호 표지
DOI QR코드

DOI QR Code

Distribution of medical status and medications in elderly patients treated with dental implant surgery covered by national healthcare insurance in Korea

  • Lee, Kyungjin (Department of Advanced General Dentistry, Yonsei University) ;
  • Dam, Chugeum (Department of Advanced General Dentistry, Yonsei University) ;
  • Huh, Jisun (Department of Advanced General Dentistry, Yonsei University) ;
  • Park, Kyeong-Mee (Department of Advanced General Dentistry, Yonsei University) ;
  • Kim, Seo-Yul (Department of Advanced General Dentistry, Yonsei University) ;
  • Park, Wonse (Department of Advanced General Dentistry, Yonsei University)
  • Received : 2017.06.19
  • Accepted : 2017.06.23
  • Published : 2017.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The purpose of this study was to investigate the distribution of systemic diseases and medications in patients older than 65 years of age who visited the hospital for implant treatment, as well as to investigate basic information about surgical complications that may occur after insured implant treatment. Method: A total of 126 patients over 65 years of age were treated for implant surgery from October 1, 2013 to October 30, 2016. Electronic chart review was conducted to obtain medical records, which included sex, age, systemic diseases, medication(s) being taken, and control of the medications. Five patients were excluded due to lack of medical records giving information about systemic disease. Results: Of the 126 patients, 112 (88.9%) were taking medication due to systemic disease and 9 patients (7.1%) were not. The sex distribution was 71 women and 55 men and the highest proportion of patients were between 65 and 69 years old. The most common diseases were, from most to least frequent, hypertension, cardiovascular disease, diabetes, and osteoporosis. The drug groups that can cause major complications after dental treatment were classified as hemorrhagic, osteoporotic, and immunosuppressive agents, and were taken by 45 (35.7%), 22 (17.5%) and 4 (3.2%) patients, respectively. Conclusion: Given that 88.9% of the elderly patients who were eligible for insurance implant treatment had systemic disease, it is necessary to carefully evaluate patients' medical histories and their general conditions in order to prevent emergencies during implant surgery.

Keywords

References

  1. Manor Y, Simon R, Haim D, Garfunkel A, Moses O. Dental implants in medically complex patients-a retrospective study. Clin Oral Investig 2017; 21: 701-8. https://doi.org/10.1007/s00784-016-1937-6
  2. Woo HK, Shin EJ, Lim JM, Lee HS, Kim HS. Drug use review, analysis, and adequacy assessment of elderly outpatients. J Kor Soc Health-Syst Pharm 2014; 31: 983-91.
  3. Goodacre CJ, Bernal G, Rungcharassaeng K, Kan JY. Clinical complications with implants and implant prostheses. J Prosthet Dent 2003; 90: 121-32. https://doi.org/10.1016/S0022-3913(03)00212-9
  4. Zarb GA, Schmitt A. Implant therapy alternatives for geriatric edentulous patients. Gerodontology 1993; 10: 28-32. https://doi.org/10.1111/j.1741-2358.1993.tb00076.x
  5. Diz P, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent 2013; 41: 195-206. https://doi.org/10.1016/j.jdent.2012.12.008
  6. Doonquah L, Mitchell AD. Oral surgery for patients on anticoagulant therapy: Current thoughts on patient management. Dent Clin North Am 2012; 56: 25-41. https://doi.org/10.1016/j.cden.2011.06.002
  7. Hirsh J, Levine M. Low molecular weight heparin. Blood 1992; 79: 1-17.
  8. Hellstein JW, Adler RA, Edwards B, Jacobsen PL, Kalmar JR, Koka S, et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the american dental association council on scientific affairs. J Am Dent Assoc 2011; 142: 1243-51. https://doi.org/10.14219/jada.archive.2011.0108
  9. Baron R, Ferrari S, Russell RGG. Denosumab and bisphosphonates: Different mechanisms of action and effects. Bone 2011; 48: 677-92. https://doi.org/10.1016/j.bone.2010.11.020
  10. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American association of oral and maxillofacial surgeons position paper on medication- related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 2014; 72: 1938-56. https://doi.org/10.1016/j.joms.2014.04.031
  11. Food and Drug Administration. Background document for meeting of advisory committee for reproductive health drugs and drug safety and risk management advisory committee. Center for Drug Evaluation and Research 2011, pp 17-20.
  12. Guggenheimer J, Eghtesad B, Stock DJ. Dental management of the (solid) organ transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 383-9. https://doi.org/10.1067/moe.2003.150

Cited by

  1. Comparing factors affecting dental‐implant loss between age groups: A retrospective cohort study vol.23, pp.2, 2017, https://doi.org/10.1111/cid.12967
  2. Analysis of interest in implant using a big data: A web-based study vol.59, pp.2, 2017, https://doi.org/10.4047/jkap.2021.59.2.164